Trade CVS Health - CVS CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.27 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.030779% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | -0.013666% | ||||||||
Overnight fee time | 22:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 20% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
CVS Health Corp ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 85.93 |
Open* | 88.48 |
1-Year Change* | -19% |
Day's Range* | 88.48 - 90.11 |
52 wk Range | 84.82-111.25 |
Average Volume (10 days) | 10.08M |
Average Volume (3 months) | 147.94M |
Market Cap | 112.02B |
P/E Ratio | 36.23 |
Shares Outstanding | 1.31B |
Revenue | 315.23B |
EPS | 2.35 |
Dividend (Yield %) | 2.83871 |
Beta | 0.62 |
Next Earnings Date | Feb 8, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Feb 7, 2023 | 85.93 | 0.91 | 1.07% | 85.02 | 86.56 | 84.44 |
Feb 6, 2023 | 85.18 | -0.18 | -0.21% | 85.36 | 86.51 | 85.10 |
Feb 3, 2023 | 85.70 | -0.79 | -0.91% | 86.49 | 87.52 | 85.52 |
Feb 2, 2023 | 86.07 | -0.02 | -0.02% | 86.09 | 86.91 | 85.35 |
Feb 1, 2023 | 87.36 | -0.55 | -0.63% | 87.91 | 88.10 | 86.53 |
Jan 31, 2023 | 88.09 | 1.24 | 1.43% | 86.85 | 88.41 | 86.85 |
Jan 30, 2023 | 86.98 | -0.82 | -0.93% | 87.80 | 88.29 | 86.91 |
Jan 27, 2023 | 87.68 | 0.03 | 0.03% | 87.65 | 88.04 | 86.92 |
Jan 26, 2023 | 87.55 | 1.18 | 1.37% | 86.37 | 87.69 | 85.95 |
Jan 25, 2023 | 85.68 | 0.63 | 0.74% | 85.05 | 85.94 | 84.75 |
Jan 24, 2023 | 85.95 | -0.47 | -0.54% | 86.42 | 86.91 | 85.84 |
Jan 23, 2023 | 87.13 | 0.28 | 0.32% | 86.85 | 87.38 | 86.51 |
Jan 20, 2023 | 86.93 | -0.41 | -0.47% | 87.34 | 87.41 | 86.69 |
Jan 19, 2023 | 87.40 | 0.27 | 0.31% | 87.13 | 88.22 | 86.94 |
Jan 18, 2023 | 88.09 | -1.36 | -1.52% | 89.45 | 89.64 | 87.96 |
Jan 17, 2023 | 89.26 | -0.74 | -0.82% | 90.00 | 90.43 | 89.03 |
Jan 13, 2023 | 89.83 | 1.20 | 1.35% | 88.63 | 90.33 | 88.45 |
Jan 12, 2023 | 89.11 | -0.55 | -0.61% | 89.66 | 89.90 | 88.94 |
Jan 11, 2023 | 89.71 | -1.87 | -2.04% | 91.58 | 91.58 | 89.29 |
Jan 10, 2023 | 90.56 | 0.31 | 0.34% | 90.25 | 91.29 | 88.40 |
CVS Health Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total revenue | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
Revenue | 177546 | 184786 | 194579 | 256776 | 268706 | 292111 |
Cost of Revenue, Total | 146533 | 153448 | 156447 | 158719 | 163981 | 175803 |
Gross Profit | 31013 | 31338 | 38132 | 98057 | 104725 | 116308 |
Total Operating Expense | 167803 | 175248 | 190558 | 244868 | 256235 | 279370 |
Selling/General/Admin. Expenses, Total | 18448 | 18809 | 21368 | 396 | 461 | 523 |
Unusual Expense (Income) | 643 | 181 | 6149 | 559 | 1503 | 2373 |
Other Operating Expenses, Total | 2179 | 2810 | 6594 | 85194 | 90290 | 100671 |
Operating Income | 9743 | 9538 | 4021 | 11908 | 12471 | 12741 |
Interest Income (Expense), Net Non-Operating | -1078 | -1062 | -2619 | -3035 | -2907 | -2503 |
Other, Net | -28 | -208 | 4 | 124 | 206 | 182 |
Net Income Before Taxes | 8637 | 8268 | 1406 | 8997 | 9770 | 10420 |
Net Income After Taxes | 5320 | 5131 | -696 | 6631 | 7201 | 7898 |
Minority Interest | -2 | -1 | 2 | 3 | -13 | 12 |
Net Income Before Extra. Items | 5318 | 5130 | -694 | 6634 | 7188 | 7910 |
Total Extraordinary Items | -1 | 1492 | 100 | 0 | -9 | 0 |
Net Income | 5317 | 6622 | -594 | 6634 | 7179 | 7910 |
Total Adjustments to Net Income | -26 | -16 | -3 | 0 | 0 | |
Income Available to Common Excl. Extra. Items | 5292 | 5114 | -697 | 6634 | 7188 | 7910 |
Income Available to Common Incl. Extra. Items | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
Diluted Net Income | 5291 | 6606 | -597 | 6634 | 7179 | 7910 |
Diluted Weighted Average Shares | 1079 | 1024 | 1044 | 1305 | 1314 | 1329 |
Diluted EPS Excluding Extraordinary Items | 4.90454 | 4.99414 | -0.66762 | 5.08352 | 5.47032 | 5.95184 |
Dividends per Share - Common Stock Primary Issue | 1.7 | 2 | 2 | 2 | 2 | 2 |
Diluted Normalized EPS | 5.2716 | 5.10383 | 3.16078 | 5.51501 | 6.31339 | 7.27044 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
Total revenue | 69097 | 72616 | 73794 | 76604 | 76826 |
Revenue | 69097 | 72616 | 73794 | 76604 | 76826 |
Cost of Revenue, Total | 40894 | 43520 | 45011 | 46378 | 45509 |
Gross Profit | 28203 | 29096 | 28783 | 30226 | 31317 |
Total Operating Expense | 65520 | 68290 | 71096 | 74464 | 73336 |
Selling/General/Admin. Expenses, Total | 8881 | 8829 | 9190 | ||
Unusual Expense (Income) | 41 | 40 | 814 | 1478 | 525 |
Other Operating Expenses, Total | 15704 | 15901 | 16081 | 26608 | 27302 |
Operating Income | 3577 | 4326 | 2698 | 2140 | 3490 |
Interest Income (Expense), Net Non-Operating | -657 | -636 | -602 | -608 | -586 |
Other, Net | 50 | 45 | 49 | 38 | 42 |
Net Income Before Taxes | 2970 | 3735 | 2145 | 1570 | 2946 |
Net Income After Taxes | 2224 | 2791 | 1587 | 1296 | 2313 |
Minority Interest | -1 | -8 | 11 | 10 | -1 |
Net Income Before Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Net Income | 2223 | 2783 | 1598 | 1306 | 2312 |
Income Available to Common Excl. Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Income Available to Common Incl. Extra. Items | 2223 | 2783 | 1598 | 1306 | 2312 |
Diluted Net Income | 2223 | 2783 | 1598 | 1306 | 2312 |
Diluted Weighted Average Shares | 1322 | 1327 | 1329 | 1338 | 1328 |
Diluted EPS Excluding Extraordinary Items | 1.68154 | 2.09721 | 1.20241 | 0.97608 | 1.74096 |
Dividends per Share - Common Stock Primary Issue | 0.5 | 0.5 | 0.5 | 0.5 | 0.55 |
Diluted Normalized EPS | 1.70477 | 2.08539 | 1.65557 | 1.88793 | 2.05135 |
Total Extraordinary Items | 0 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Total Current Assets | 31042 | 31229 | 45243 | 50302 | 56369 | 60008 |
Cash and Short Term Investments | 3458 | 1807 | 6581 | 8056 | 10854 | 12525 |
Cash & Equivalents | 3371 | 1696 | 4059 | 5683 | 7854 | 9408 |
Short Term Investments | 87 | 111 | 2522 | 2373 | 3000 | 3117 |
Total Receivables, Net | 12164 | 13181 | 17631 | 19617 | 21742 | 24431 |
Accounts Receivable - Trade, Net | 12164 | 13181 | 17631 | 17236 | 7101 | 7932 |
Total Inventory | 14760 | 15296 | 16450 | 17516 | 18496 | 17760 |
Other Current Assets, Total | 660 | 945 | 4581 | 5113 | 5277 | 5292 |
Total Assets | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
Property/Plant/Equipment, Total - Net | 10175 | 10292 | 11349 | 32904 | 33335 | 32018 |
Property/Plant/Equipment, Total - Gross | 22802 | 24290 | 26869 | 49794 | 52035 | 52672 |
Accumulated Depreciation, Total | -12627 | -13998 | -15520 | -16890 | -18700 | -20654 |
Goodwill, Net | 38249 | 38451 | 78678 | 79749 | 79552 | 79121 |
Intangibles, Net | 13511 | 13630 | 36524 | 33121 | 31142 | 29026 |
Other Long Term Assets, Total | 1485 | 1529 | 8930 | 9059 | 9505 | 9801 |
Total Current Liabilities | 26250 | 30648 | 44009 | 53303 | 62017 | 67807 |
Accounts Payable | 17397 | 19218 | 26437 | 30972 | 34869 | 38682 |
Accrued Expenses | 6937 | 6609 | 10711 | 13656 | 15810 | 19229 |
Notes Payable/Short Term Debt | 1874 | 1276 | 720 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 42 | 3545 | 1265 | 3781 | 5440 | 4205 |
Total Liabilities | 57632 | 57440 | 138231 | 158585 | 161326 | 157924 |
Total Long Term Debt | 25615 | 22181 | 71444 | 64699 | 59207 | 51971 |
Long Term Debt | 25615 | 22181 | 71444 | 63918 | 58157 | 50721 |
Deferred Income Tax | 4214 | 2996 | 7677 | 7294 | 6794 | 6270 |
Minority Interest | 4 | 4 | 318 | 306 | 312 | 306 |
Other Liabilities, Total | 1549 | 1611 | 14783 | 32983 | 32996 | 31570 |
Total Equity | 36830 | 37691 | 58225 | 63864 | 69389 | 75075 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock | 17 | 17 | 45440 | 45972 | 46513 | 47377 |
Additional Paid-In Capital | 31618 | 32079 | ||||
Retained Earnings (Accumulated Deficit) | 38983 | 43556 | 40911 | 45108 | 49640 | 54906 |
Treasury Stock - Common | -33483 | -37796 | -28228 | -28235 | -28178 | -28173 |
Other Equity, Total | -305 | -165 | 5 | 245 | 200 | 187 |
Total Liabilities & Shareholders’ Equity | 94462 | 95131 | 196456 | 222449 | 230715 | 232999 |
Total Common Shares Outstanding | 1061 | 1014 | 1295 | 1302 | 1310 | 1322 |
Long Term Investments | 15732 | 17314 | 20812 | 23025 | ||
Other Current Liabilities, Total | 4876 | 4894 | 5898 | 5691 | ||
Unrealized Gain (Loss) | 97 | 774 | 1214 | 778 | ||
Capital Lease Obligations | 781 | 1050 | 1250 | |||
Total Preferred Shares Outstanding | 0 | 0 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 55719 | 56559 | 60842 | 60008 | 61483 |
Cash and Short Term Investments | 8788 | 10125 | 12841 | 12525 | 11342 |
Cash & Equivalents | 5598 | 7119 | 9826 | 9408 | 8442 |
Short Term Investments | 3190 | 3006 | 3015 | 3117 | 2900 |
Total Receivables, Net | 23855 | 24164 | 25283 | 24431 | 26451 |
Accounts Receivable - Trade, Net | 18304 | 18976 | 8398 | 7932 | 8728 |
Total Inventory | 17618 | 16979 | 17399 | 17760 | 18160 |
Other Current Assets, Total | 5458 | 5291 | 5319 | 5292 | 5530 |
Total Assets | 229606 | 231164 | 234891 | 232999 | 232873 |
Property/Plant/Equipment, Total - Net | 33153 | 33140 | 33233 | 32018 | 31645 |
Goodwill, Net | 79552 | 79552 | 79121 | 79121 | 79060 |
Intangibles, Net | 30639 | 30080 | 29545 | 29026 | 28543 |
Long Term Investments | 21025 | 22136 | 22370 | 23025 | 22595 |
Other Long Term Assets, Total | 9518 | 9697 | 9780 | 9801 | 9547 |
Total Current Liabilities | 60104 | 59311 | 64709 | 67807 | 69780 |
Accounts Payable | 35358 | 36691 | 39468 | 38682 | 41570 |
Accrued Expenses | 16018 | 16539 | 17871 | 19229 | 18388 |
Notes Payable/Short Term Debt | 252 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2422 | 60 | 1561 | 4205 | 4217 |
Other Current Liabilities, Total | 6054 | 6021 | 5809 | 5691 | 5605 |
Total Liabilities | 158756 | 157920 | 160583 | 157924 | 159043 |
Total Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
Long Term Debt | 59270 | 59294 | 56832 | 51971 | 52063 |
Deferred Income Tax | 6610 | 6557 | 6329 | 6270 | 5829 |
Minority Interest | 314 | 321 | 310 | 306 | 310 |
Other Liabilities, Total | 32458 | 32437 | 32403 | 31570 | 31061 |
Total Equity | 70850 | 73244 | 74308 | 75075 | 73830 |
Preferred Stock - Non Redeemable, Net | 0 | 0 | 0 | 0 | 0 |
Common Stock | 46727 | 46995 | 47133 | 47377 | 47677 |
Retained Earnings (Accumulated Deficit) | 51203 | 53331 | 54264 | 54906 | 56488 |
Treasury Stock - Common | -28102 | -28252 | -28166 | -28173 | -30145 |
Unrealized Gain (Loss) | 828 | 977 | 904 | 778 | -377 |
Other Equity, Total | 194 | 193 | 173 | 187 | 187 |
Total Liabilities & Shareholders’ Equity | 229606 | 231164 | 234891 | 232999 | 232873 |
Total Common Shares Outstanding | 1313 | 1318 | 1321 | 1322 | 1306 |
- Annual
- Quarterly
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Cash From Operating Activities | 10141 | 8007 | 8865 | 12848 | 15865 | 18265 |
Cash Receipts | 172310 | 176594 | 186519 | 248393 | 264327 | 284219 |
Cash Payments | -142511 | -146469 | -148821 | -149655 | -158636 | -165783 |
Cash Taxes Paid | -3060 | -2909 | -2383 | -2717 | -2929 | -3195 |
Cash Interest Paid | -1140 | -1072 | -2803 | -2954 | -2904 | -2469 |
Changes in Working Capital | -15458 | -18137 | -23647 | -80219 | -83993 | -94507 |
Cash From Investing Activities | -2470 | -2877 | -43285 | -3339 | -5534 | -5261 |
Capital Expenditures | -2224 | -1918 | -2037 | -2457 | -2437 | -2520 |
Other Investing Cash Flow Items, Total | -246 | -959 | -41248 | -882 | -3097 | -2741 |
Cash From Financing Activities | -6761 | -6751 | 36819 | -7654 | -7696 | -11356 |
Financing Cash Flow Items | -142 | -72 | 350 | 59 | 337 | -13 |
Total Cash Dividends Paid | -1840 | -2049 | -2038 | -2603 | -2624 | -2625 |
Issuance (Retirement) of Stock, Net | -4165 | -4032 | 242 | 210 | 264 | 549 |
Issuance (Retirement) of Debt, Net | -614 | -598 | 38265 | -5320 | -5673 | -9267 |
Foreign Exchange Effects | 2 | 1 | -4 | |||
Net Change in Cash | 912 | -1620 | 2395 | 1855 | 2635 | 1648 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Cash From Operating Activities | 2892 | 8739 | 14260 | 18265 | 3563 |
Cash Receipts | 66487 | 136621 | 209104 | 284219 | 74192 |
Cash Payments | -39171 | -79316 | -122129 | -165783 | -44365 |
Cash Taxes Paid | -44 | -1552 | -2397 | -3195 | -96 |
Cash Interest Paid | -876 | -1263 | -2095 | -2469 | -782 |
Changes in Working Capital | -23504 | -45751 | -68223 | -94507 | -25386 |
Cash From Investing Activities | -1867 | -2974 | -3821 | -5261 | -1993 |
Capital Expenditures | -829 | -1315 | -1923 | -2520 | -1082 |
Other Investing Cash Flow Items, Total | -1038 | -1659 | -1898 | -2741 | -911 |
Cash From Financing Activities | -3185 | -6558 | -8525 | -11356 | -2650 |
Financing Cash Flow Items | 56 | -159 | -164 | -13 | -211 |
Total Cash Dividends Paid | -656 | -1306 | -1965 | -2625 | -722 |
Issuance (Retirement) of Stock, Net | 212 | 330 | 440 | 549 | -1703 |
Issuance (Retirement) of Debt, Net | -2797 | -5423 | -6836 | -9267 | -14 |
Net Change in Cash | -2160 | -793 | 1914 | 1648 | -1080 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 8.7762 | 115316851 | 1721829 | 2022-09-30 | LOW |
Capital World Investors | Investment Advisor | 4.6346 | 60896763 | 2060715 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 4.586 | 60258711 | 234645 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 4.4403 | 58344728 | -339582 | 2022-09-30 | LOW |
Capital International Investors | Investment Advisor | 1.9717 | 25907490 | -351533 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.7789 | 23374421 | 186288 | 2022-09-30 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 1.6592 | 21801147 | 696280 | 2022-09-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.5392 | 20224681 | 368634 | 2022-09-30 | LOW |
BofA Global Research (US) | Research Firm | 1.1617 | 15264714 | 80812 | 2022-09-30 | LOW |
Dodge & Cox | Investment Advisor/Hedge Fund | 1.0254 | 13472772 | -236945 | 2022-09-30 | LOW |
Invesco Advisers, Inc. | Investment Advisor | 0.9993 | 13129851 | -500609 | 2022-09-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.9936 | 13055500 | -67996 | 2021-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.9056 | 11899729 | 224538 | 2022-09-30 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.7675 | 10085134 | -130262 | 2022-09-30 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.7495 | 9847659 | -473501 | 2022-09-30 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.726 | 9539067 | -771778 | 2022-09-30 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.7187 | 9443400 | -8279 | 2022-09-30 | LOW |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 0.6884 | 9045542 | -197163 | 2022-09-30 | LOW |
Northern Trust Investments, Inc. | Investment Advisor/Hedge Fund | 0.673 | 8843195 | -63183 | 2022-09-30 | LOW |
Nordea Funds Oy | Investment Advisor | 0.6619 | 8697324 | -983166 | 2022-09-30 | LOW |
Why choose Capital.com? Our numbers speak for themselves.
Capital.com GroupTraders
Active clients monthly
Monthly investing volume
Withdrawn each month
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
CVS Company profile
CVS Health (CVS) is an American health service provider headquartered in Woonsocket, Rhode Island.
In 1963, brothers Stanley and Sidney Goldstein, and Ralph Hoagland founded the company in Lowell, Massachusetts. The first CVS store sold health and beauty products. CVS stands for Consumer Value Stores.
CVS Health has four business segments: Health Care Benefits, Pharmacy Services, Retail/LTC and Corporate/Other.
The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, MedicareAdvantage and health information. The segment serves around 35 million customers, including employer groups, individuals, college students, part-time and hourly workers, health care providers, government-sponsored plans, labour groups and expatriates.
The Pharmacy Services segment provides pharmacy benefit management (PBM) solutions, including, plan design offerings and administration, formulary management, retail pharmacy network management services, mail order pharmacy, clinical services and disease management services. The segment’s customers include employers, insurance companies, unions, government employee groups, health plans, plans offered on insurance exchanges and other sponsors of health benefit plans.
The Retail/LTC segment sells prescription drugs, health and wellness products, and general merchandise. It also provides health care services through its MinuteClinic walk-in medical clinics, medical diagnostic testing, and administers vaccinations for illnesses such as influenza and Covid-19.
Long-term care pharmacy operations are also part of the segment. They distribute prescription pharmaceuticals as well as provide pharmacy consulting and other ancillary services to care homes and other care settings.
As of 31 December 2021, the Retail/LTC segment operated more than 9,900 locations, nearly 1,200 MinuteClinic locations, online services, LTC pharmacies and on-site pharmacies. CVS Health announced in November 2021 that it plans to close 900 stores in the next three years as part of its strategy to overhaul its retail business. The closures will start in spring 2022.
The company dispensed about 26.4% of all retail pharmacy prescriptions in the US in 2021.
The Corporate/Other segment provides management and administrative expenses to support the Company’s overall operations. It also offers products for which the company no longer solicits or accepts new customers such as large case pensions and long-term care insurance products.
The company’s shares are traded on the New York Stock Exchange under the ticker symbol CVS.
Industry: | Healthcare Facilities & Services (NEC) |
1 Cvs Dr
WOONSOCKET
RHODE ISLAND 02895-6146
US
Income Statement
- Annual
- Quarterly
News

Markets look for guidance after Powell speech, eyeing US CPI: USD, S&P 500, DAX 40
Us equities try to build appetite to push higher after Powell acknowledges disinflation during his speech
12:34, 8 February 2023
Ripple/SEC Lawsuit: News And Update
Ripple and the US Securities and Exchange Commission are still awaiting a ruling
15:00, 7 February 2023
Gold Price Forecast: Gold Loses Shine as USD and US Yields Edge Higher
Gold correcting lower on USD comeback. Eyes on Chair Powell to exacerbate Gold downside
12:41, 7 February 2023
Australian Dollar Outlook: AUD/USD bounces back as RBA hikes 25bps
AUS/USD bounces higher as RBA delivers its 9th rate hike
11:28, 7 February 2023
Japanese Yen Outlook: USD/JPY Edging Towards YTD Peak on BoJ Dove and US Yields
Japanese Yen underperforms with BoJ dove touted to be Governor Kuroda successor.
14:36, 6 February 2023People also watch
Still looking for a broker you can trust?
Join the 500.000+ traders worldwide that chose to trade with Capital.com